122 related articles for article (PubMed ID: 2827319)
1. Limited stage small cell lung cancer: analysis of clinical prognostic factors.
Hainsworth JD; Johnson DH; Farese RV; Macey JW; Vaughn WK; Greco FA
South Med J; 1987 Dec; 80(12):1518-22. PubMed ID: 2827319
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.
Osterlind K; Andersen PK
Cancer Res; 1986 Aug; 46(8):4189-94. PubMed ID: 3015384
[TBL] [Abstract][Full Text] [Related]
3. Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).
Byhardt RW; Hartz A; Libnoch JA; Hansen R; Cox JD
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):771-7. PubMed ID: 3011712
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and prognostic staging system for small cell lung cancer.
Kawahara M; Fukuoka M; Saijo N; Nishiwaki Y; Ikegami H; Tamura T; Shimoyama M; Suemasu K; Furuse K
Jpn J Clin Oncol; 1997 Jun; 27(3):158-65. PubMed ID: 9255270
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors in unresectable lung cancer].
Urata A
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.
Lassen U; Osterlind K; Hansen M; Dombernowsky P; Bergman B; Hansen HH
J Clin Oncol; 1995 May; 13(5):1215-20. PubMed ID: 7738624
[TBL] [Abstract][Full Text] [Related]
8. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients.
Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G
Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in small cell lung cancer: multivariate analysis in the National Cancer Center Hospital (Japan).
Shinkai T; Sakurai M; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Fukuda M; Yamada K; Kojima A; Sasaki S
Jpn J Clin Oncol; 1989 Jun; 19(2):135-41. PubMed ID: 2543848
[TBL] [Abstract][Full Text] [Related]
10. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis.
Hermes A; Gatzemeier U; Waschki B; Reck M
Respir Med; 2010 Dec; 104(12):1937-42. PubMed ID: 20719490
[TBL] [Abstract][Full Text] [Related]
11. The importance of surgical and multimodality treatment for small cell bronchial carcinoma.
Karrer K; Shields TW; Denck H; Hrabar B; Vogt-Moykopf I; Salzer GM
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):168-76. PubMed ID: 2536867
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
[TBL] [Abstract][Full Text] [Related]
13. Large cell carcinoma of the lung: a highly aggressive tumor with dismal prognosis.
Downey RS; Sewell CW; Mansour KA
Ann Thorac Surg; 1989 Jun; 47(6):806-8. PubMed ID: 2547348
[TBL] [Abstract][Full Text] [Related]
14. Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.
Gronowitz JS; Bergström R; Nôu E; Påhlman S; Brodin O; Nilsson S; Källander CF
Cancer; 1990 Aug; 66(4):722-32. PubMed ID: 2167141
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment serum LDH as additional staging parameter in small-cell lung carcinoma.
Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Neth J Med; 1998 Feb; 52(2):65-70. PubMed ID: 9557528
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
Shepherd FA; Ginsberg RJ; Patterson GA; Evans WK; Feld R
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
[TBL] [Abstract][Full Text] [Related]
17. Multimodal therapy of small cell lung cancer in TNM stages I through IIIa.
Müller LC; Salzer GM; Huber H; Prior C; Ebner I; Frommhold H; Präuer HW
Ann Thorac Surg; 1992 Sep; 54(3):493-7. PubMed ID: 1324655
[TBL] [Abstract][Full Text] [Related]
18. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
20. Intensive combined modality therapy for limited-stage small-cell lung cancer.
Elias AD; Ayash L; Frei E; Skarin AT; Hunt M; Wheeler C; Schwartz G; Mazanet R; Tepler I; Eder JP
J Natl Cancer Inst; 1993 Apr; 85(7):559-66. PubMed ID: 8384264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
